Repligen Corporation

RGN.F·Frankfurt·Healthcare
Compare
157.95−1.85 (−1.16%)today
As of Oct 21, 8:04 AM CEST · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close159.80
Open157.95
Day range—
52-week range86.32170.65
Off day high0.00%
Off 52-week high−7.44%
Volume20.00
Avg. volume (3M)12.00
Market cap10.03B
EPS (TTM)0.6300
Forward P/E52.30
P/E ratio (TTM)250.71
Dividend yield—
Beta (5Y)1.08
Shares outstanding63.49M
Short interest—
Earnings dateOct 27, 2026
Analyst target—
Profit margin5.29%

Against its peers

Compare in full ›
RGN.F SRT3.DE BLFS AVTR DIM.PA AZTA
Market cap 10.03B 18.03B — 11.67B 20.96B 1.61B
P/E (TTM) 250.7 95.3 — — 71.6 —
Forward P/E 52.3 41.2 — 19.7 35.8 66.5
Price/book 4.7 6.7 — 2.1 4.9 1.1
Dividend yield — 0.28% — — 0.33% —
1-year change +19.61% +10.48% — +9.63% +1.32% +12.68%
Today −1.16% −1.36% 0.00% +3.85% +0.19% +2.88%

The closest companies by business and industry (Medical Instruments & Supplies). Prices may be delayed up to 15 min.

Latest news

All RGN.F news ›
Seeking Alpha·Positive

Repligen: A Buy As Its Growth Engine Gears Up

(NASDAQ:RGEN) Seeking Alpha - Repligen demonstrates 13% organic growth despite Filtration headwinds, with strong momentum in the Proteins and Process Analytics segments. - Filtration's drag is temporary, with mid-single-digit growth…

GlobeNewswire News Room·

Repligen to Report Third Quarter 2026 Financial Results

GlobeNewswire 13, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), today announced that the Company will report its third quarter 2026 financial results on Tuesday, October 27, 2026 The Company will issue a press release before…

From articles in the 4Search news index.

In the news

12mentions in 30 days
12with it in the headline
Mixedsentiment

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 12 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.